Head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, with low
survival rates for advanced stage tumors and minimal improvement in survival trends …

Breast Cancer (BC) is the second most frequent cause of cancer death among women
worldwide and, although there have been significant advances in BC therapies, a significant …

Immune systems have evolved to recognize and eliminate pathogens and damaged cells. In
humans, it is estimated to recognize 10 9 epitopes and natural selection ensures that …

Background To date, epidemiological evidence of the association between preoperative
prognostic nutritional index (PNI) and the prognosis of hepatocellular carcinoma (HCC) …

Background Patients with solid tumours have high COVID-19 mortality. Limited and
heterogeneous data are available regarding the immunogenicity of SARS-CoV-2 mRNA …

Head and neck cancer (HNC) is one of the most common cancers worldwide. Alcohol and
tobacco consumption, besides viral infections, are the main risk factors associated with this …

Cancer immunotherapy is a rapidly evolving and paradigm shifting treatment modality that
adds a strong tool to the collective cancer treatment arsenal. It can be effective even for late …

Therapeutic approaches that engage immune cells to treat cancer are becoming
increasingly utilized in the clinics and demonstrated durable clinical benefit in several solid …

Regulatory T (Treg) cells are a group of cells that are heterogeneous in origin and in
functional activity. Treg cells comprise a necessary balance to adaptive immune responses …

Rationale, aims, and objectives Acute postoperative pain can result in immune dysfunction,
which can be partly mitigated by efficient pain management. Opioids that have been widely …